Skip to main content

Table 7 Comparison of the clinical characteristics of chronic hepatitis C patients with (A2–3) or without (A0–1) severe hepatic inflammation

From: Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C

  

A0-A1

 

A2-A3

   
  

n = 32

 

n = 45

   

Factor

Mean or number

Maximum

Minimum

Mean or number

Maximum

Minimum

P value*

Age (years)

51.9

70

20

59.1

76

24

0.039

Sex (male/female)

14/18

  

17/28

  

0.598

Body mass index (kg/m2)

23.1

30.1

16.4

23.7

32.2

17.8

0.694

Platelets (×104/μl)

21.3

41.9

11.1

15.8

39.7

5.4

<0.001

Total cholesterol (mg/dl)

180.9

295

101

163.4

251

84

0.122

Albumin (g/dl)

4.4

5.1

3.3

4.2

4.9

2.9

0.003

ALT (IU/l)

42.2

165

13

80.3

244

14

0.003

γ-GTP (IU/l)

32.3

114

12

62.8

468

12

0.006

Diabetes (absent/present)

6/26

  

11/34

  

0.553

Fasting plasma glucose (mg/dl)

97.8

196

75

96.5

176

72

0.983

Hemoglobin A1c (%)

5.4 (n = 31)

7.6

4.6

5.4 (n = 44)

7.1

4.7

0.643

Leptin (ng/ml)

7.2

21.8

1

7.8

20.7

1.1

0.247

Adiponectin (ng/ml)

8.9

27.3

1.1

9

26.7

1.7

0.463

Resistin (ng/ml)

8.6

27.6

2.5

8.5

19.7

3

0.687

AIM (μg/ml)

1.17

4.56

0.41

1.54

6.44

0.76

0.001

Hyaluronic acid (ng/ml)

58.8

10.0

292.7

123.4 (n = 43)

12.1

636.0

0.001

  1. *Calculated by Chi-square test for categorical variables or Mann–Whitney U test for continuous variables.
  2. ALT, alanine aminotransferase; γGTP, γ-glutamyl transpeptidase; HOMA-IR, homeostasis model assessment-insulin resistance; AIM, apoptosis inhibitor of macrophage.